Fennec Pharmaceuticals CFO Robert Andrade sells 75,000 common shares for $883,500
FENC•Insider share sale and option exercise
- Fennec Pharmaceuticals CFO Robert Andrade sold 75,000 common shares on Aug. 27 at $11.78.
- He exercised stock options on Aug. 28 to acquire 21,928 common shares at $5.10.
- Directly held common shares totaled 239,603 following the transactions.
- Directly held stock options totaled 779,330 following the option exercise.
